Toxic gastroenteritis and colitis
ICD-10 K52.1 is a billable code used to indicate a diagnosis of toxic gastroenteritis and colitis.
Toxic gastroenteritis and colitis (K52.1) is characterized by inflammation of the gastrointestinal tract, specifically the stomach and intestines, due to exposure to toxic substances, including certain chemicals, drugs, or infectious agents. Clinically, patients may present with symptoms such as severe abdominal pain, diarrhea (which may be bloody), nausea, vomiting, and fever. The anatomy involved includes the stomach, small intestine, and large intestine, where the inflammatory response can lead to mucosal damage and disruption of normal gastrointestinal function. Disease progression can vary; in mild cases, symptoms may resolve with supportive care, while severe cases can lead to dehydration, electrolyte imbalances, and systemic complications. Diagnostic considerations include a thorough patient history to identify potential toxin exposure, laboratory tests to assess electrolyte levels and kidney function, and stool studies to rule out infectious causes. Imaging studies may be warranted in cases of severe abdominal pain to exclude other conditions.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K52.1 covers gastroenteritis and colitis resulting from toxic substances, including chemical ingestion, drug reactions, and certain foodborne toxins. It does not include infections or non-toxic causes.
K52.1 should be used when there is clear evidence of toxic exposure leading to gastrointestinal symptoms, differentiating it from codes for infectious or non-toxic gastroenteritis.
Documentation should include a detailed patient history of potential toxin exposure, clinical findings, laboratory results, and treatment provided. Clear linkage between symptoms and toxic exposure is crucial.
